Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1053 U.S. listed China Stocks and Counting...
 Tracking 1536 U.S. Stocks and Counting...

China Earnings Recap, March 3, 2011

Thursday, March 3, 2011, 3:30 PM ET -

    Below is a recap of some latest Chinese company earnings compared to estimates and prior period, with links to their commentaries or releases. Note: This list may be updated throughout the day, up to and including the guidance comments!
    

ChinaHybrid™ companies have begun to report financial results over the past three weeks. We believe it is important to provide investors with year end updates on these companies so investors can begin to sift through the volumes of information in order to identify stocks that may offer the best chance of success during 2011, as well as the challenges that exist.

Over the course of the year-end results schedule coming out of China, we will be making all of our data available, real time, on the GeoBlog. Please check back daily, as the spreadsheet will be constantly updated.

We are compiling our wish list of stocks to watch in 2011. Once narrowed down, we will pull SAIC filings to verify if they match SEC filings. Ideally, we are searching for companies that:

  • reported superb EPS growth,
  • and/or expect superior growth for 2011;
  • offer minimal dilution risk;
  • possess effective internal controls;
  • do not retain controversial auditors;
  • and/or are in the midst of upgrading auditors

We have eliminated CDII, SGTI, CJJD, SCOK, and CPSL. All of these companies have retained auditors that have come under fire in recent months.  All but CPSL have ineffective internal controls; however, near term growth outlook will be uncertain due to industry dynamics. Furthermore, a capital raise appears to be a high priority.. SCOK's business has been negatively affected by government legislation resulting in a temporary shutdown of mining operations in their locale. We will revisit story at the end of March, when restrictions are expected to be lifted. CJJD has been a laggard since its entry into the public markets and is now looking at a challenging competitive environment leading to subpar EPS growth estimates, that call for under 15% for fiscal 2012. CDII gave impressive net income guidance but without EPS guidance. Additionally, taking into account their propensity to raise money, we believe another capital raise is certainly in the cards. For investors who choose to ignore auditor/internal control risk but have faith in analyst estimates, SGTI and SCOK may be stories worth tracking. The EPS growth outlook for SGTI's next two quarters should be well above average; however, unless estimates are revised upwards, 2012 EPS growth will be anemic at less than 10%

ANNO is a newcomer to the scene. We have done no due diligence on this company. Demand seems strong, though internal controls are ineffective and we see a high probability of a capital raise in the near future.

We have also eliminated YYIN, CGPI, CHPN, CSWG, GDHI, SINO, and CNGL. YYIN faces a challenging market environment due to the recent infant formula issues. The company commented:

“We have chosen to adjust our guidance due to the recent turbulence of China’s infant formula market, which has created a challenging environment for implementing our transformation strategy.”

We see this stock possibly headed lower to its book value per share of $0.45. CGPI is in the midst of responding to our inquiries.  We hope to have more clarity on the issue within the next seven days. CHPN Revenue growth has been anemic, catching up to its EPS growth that has turned decidedly negative. CSWG has offered no outlook. GDHI is way too early to consider and has a ton of shares outstanding. We listened to the conference call that offered lots of "aspirations and intentions". SINO is losing money and will continue to be negatively impacted by the revaluation of the $ to the RMB. We want to like CNGL, but EPS inconsistency and a penchant to raise money will currently keep us at bay for now. Overall, CHPN, CSWG, and CNGL seem likely to tap the equity markets.

Its important to note that although we have removed these companies from our consideration for the portfolio, they are still trading at absurdly low p/e multiples. If the RTO space is to recover and/or these companies improve their corporate governance quality, investors may be able to bid up the p/e multiples from current levels. Investors should pay close attention to companies with effective internal controls  whose audits are signed off by top ranked auditors. Of course, we will continue to revisit these stories for updates and developments, willing to pounce on opportunities as they occur.

Who has peaked our curiosity on the RTO front? We will closely follow newcomers OPEI, EGHA, and BFTI.

OPEI is engaged in two energy-related business segments in China, the wholesale distribution of finished oil products and the operation of retail gas stations. OPEI completed its RTO in early September 2010 and we have seen shares quietly rise from $5.75 to its current price of $8.45. The stock trades with relatively low volume on the pink sheets.

EGHA is a manufacturer of footwear and came on the scene in October of 2010. The stock is also on the pink sheets and trades low volume; however, this could change as communication flow with investors has slowly begun.

BFTI has had six quarters of year-over-year EPS growth in a row. EPS for the last three quarters has been sequentially stagnant which could imply that the company may have to tap financial markets. However, the company seems akin to exploring options other than equity financing.

Even though all three companies do not retain top auditors (though they have not been specifically targeted by the media, yet), each seems averse to using equity to finance near-term growth, claiming that debt and internal cash will be the primary sources of capital. We also like the fact that they are new kids on the block, with light volume, which will hopefully subdue short attacks for some time.  Additionally, all three have effective internal controls and have exhibited strong EPS growth. OPEI sports a P/E of 8.4. Could this imply that investors see quality here? Of the two, EGHA's prospects for near-term EPS growth seems more certain, based on company commentary:

“The Company plans to purchase more manufacturing equipment to increase its production capacity during the second half of fiscal year 2011, in order to meet increasing demands of our shoe sole products."

OPEI earnings comparisons appear more challenging in the near term. More due diligence will be required to determine short-term growth prospects.

EGHA is an FIE which means it will be easier to verify SEC numbers, as opposed to OPEI and BFTI, which are both VIE's. However, OPEI is audited by BDO—a supposed ‘top auditor.’ Other companies with unranked auditors but effective internal controls include CHHE and TPI.  We will continue to actively track both of these FIE's that were once GeoSpecials.  TPI has still not addressed issues of mismatched SAIC filings.

YTEC, LPH and ONP are RTO’s that retain what some consider to be top auditors. Since ONP has been through the ringer we may consider long term call options once its audit is completed. YTEC quarterly EPS growth is expected to be inconsistent despite showing annual growth.  LPH shares outstanding are well over our threshold for an RTO. We generally like to buy companies with outstanding shares of 25 million or less, but we will consider up to 50 million shares.

Some investors may be somewhat intrigued by CMDI, but they will require capital-- possibly why the chart is dismal despite some impressive EPS gains. Internal controls are also not in check.

We plan to pull SAIC filings on OPEI, EHGA, BFTI, and CHHE-- maybe giving us the green light to take speculative positions If trading volume eventually improves.

None of the companies in this list will be considered Tier 1 companies, as they do not have a top 6 auditors and came public via reverse mergers. The companies mentioned should only be considered by risk-seeking investors.

We did not see any IPO's with compelling value in the last week. We will be watching YGE, CMED, and HOLI for analyst estimate revisions. An interesting comparison between just these three IPO’s and the slew or RTO’s is the difference in quality of auditors—YGE is audited by KPMG; CMED by PWC; and HOLI by BDO. If these young companies can retain top auditors, the young RTO’s should theoretically have the same ability.

Please see this spreadsheet for more details.

Stay tuned as we continue to offer more insight into upcoming earnings releases. If you have companies you would like us, including our attorney Bob and our analyst Dan France, to take a look at, please send us a note

Disclosure: None 

   
 Recent Quarterly Earnings for Some U.S. Listed Chinese Companies                                                                                            
                Company                 EPS Estimate                 Reported Non-GAAP EPS                 Prior Year Reported Non-GAAP EPS                 Comments/Guidance
Yayi Intl (OTC BB:YYIN)                        (0.01)           0.01 Company reports loss and lowered guidance.  Near-term does not bode well for the company "due to the recent turbulence of China’s infant formula market, which has created a challenging environment for implementing our transformation strategy."  Capital will likely be required to grow business. May be a chance that stock gravitates to its book value per share of ~0.40. Ineffective internal controls.
Shengtai Pharmaceuticals (OTC BB:SGTI)     0.18        0.28              0.11 Muted reaction to great quarter. On track to exceed implied power point guidance of $1.00 (not including warrants with a strike of $5.20). Would be a strong buy if SEC numbers are indeed accurate. At ~ 80%, projected 2011 EPS growth looks great, but 2012 growth currently appears anemic, which could pose valuation challenges and limit P/E expansion. Pharma sector for the China RTO has not been a good one. Capital raise not an option if we are to believe management comments. Would have liked the company to have issued specific guidance in the release. (IR firm needs to wake up). Ineffective internal controls. Controversial auditor.
China Redstone Group (OTC BB:CGPI)     0.36        0.42           0.47 Company has reconsidered the tourism project. We would like more information on nature of this project to determine if costs are recoverable.  We also would like to know why  loan could not be secured for the project. Claims that it will not need for financing over the next 18 months.  EPS for fiscal 2012 is expected to increase ~17%. While this is below our preferred minimum of 30%, value investors who believe the CGPI story will see opportunity in a low PEG ratio of 0.12. Ineffective internal controls.
China Polypeptide Group (OTC BB:CHPN)                         (0.05)           0.09 Revenue growth was anemic in Fiscal 2010 and EPS growth was negative. Sales and EPS trend remains negative. Low trailing P/E may be a trap if losses continue. Will require capital. Ineffective internal controls.
China New Media (OTC BB:CMDI)                          0.05            0.04 Horrible chart despite two consecutive quarters of sales and EPS growth. "We expect to see continued growth in 2011." Might be worth a gamblers look.  Will require capital (maybe why chart is weak) Ineffective internal controls.
China Jo-Jo Drugstores (NASDAQ:CJJD)      0.19       0.17           0.26 Three quarters in a row of weak EPS growth hampered by dilution and competitive environment. EPS comp in the next Q will not be any easier, where they reported $0.39. Analysts expect EPS growth to rebound in 2010 to $0.91  Capital raise seems like a high probability.  Ineffective internal controls. Controversial auditor
China Direct Industries (NASDAQ:CDII)                                    0.09                 (0.04) Good quarter, but has had trouble with EPS consistency. Profitability should continue based on guidance, but a capital raise is a high probability. Ineffective internal controls. Controversial auditor.
Sinocoking Coal & Coke (NASDAQ:SCOK)      0.07        0.21           0.36 Still suffering from plan shut downs. Resumption of normal operations is expected after March 2011. Ineffective internal controls.  Controversial auditor
American Nano Silicon (OTC BB:ANNO)                          0.04           0.03 Demand seems strong: " Since our sales already exceed the production capacity of our plant, we are investing aggressively in an expansion of our production capacity." However we see a high chance of an equity raise in the near future. Ineffective internal controls.
Soufun Holdings Adr (NYSE:SFUN)                          0.56           0.39          No EPS growth is expected in 2011. EPS growth is expected to grow 20% in 2012. Ineffective internal controls.
Sen Yu Intl (OTC BB:CSWG)                         0.22           0.36 No comments what so ever about future outlook. Need for capital appears high:  "in addition to funds available from operations and loans from shareholders, we may need external sources of capital for expansion of our facilities and to increase the roster of our franchisee farmers, in order to reach our goal of producing one million commercial hogs in 2013." Ineffective internal controls.
Golden Dragon Holdin (PINK:GDHI)                         loss                       loss            2.5 billion shares outstanding!!!!! No thank you.
Sports Power, Inc. (PINK:EGHA)                         0.10                    0.05           This is the second quarter in row of impressive earning gains. No specific guidance, but comments indicate that gains may accelerate: "The Company plans to purchase more manufacturing equipment to increase its production capacity during the second half of fiscal year 2011, in order to meet increasing demands of our shoe sole products." Claims that debt and internal cash will be primary sources of capital.Company is on pinks. Effective internal controls. We will pull SAIC filings.
Sino-Global Shpping (NASDAQ:SINO)                         (0.04)               (0.01)           "The continued re-valuation of the RMB against the U.S. dollar is a factor that has significantly impacted Sino-Global's gross margins and will continue to be a negative factor on our bottom line performance." Sells near book for a reason. Effective internal controls.
Reconstruction Tech (NASDAQ:RCON)                          0.23           0.47 IPO. "Our second quarter was a challenging one for Recon, as we faced several unanticipated obstacles to our growth strategy." Effective internal controls.
Orient Petroleum (OTC BB:OPEI)                          0.25           0.17  Recent reverse merger. Three quarters in a row of above average EPS growth. Next quarter will be tough one, as it looks like they are going up against $0.34 in the prior yr qtr. trailing EPS of 1.05 gives stock a p/e of 7.9. Claims that debt and internal cash will be primary sources of capital.  Cashflow is negative due to an advance to supplier transaction. Effective internal controls. We will pull SAIC filings
Longwei Petroleum (NYSE AMEX:LPH)     0.15        0.12          (0.15) Company has ton of shares outstanding, but has been able to fight off dilution. "We recently renewed our supply contracts with fifteen major customers, and we plan to increase our storage capacity in the current calendar year to meet the constant growth in demand for fuel in China. We are very excited about the growth prospects in our regional market and fully expect to meet our previous guidance." Need for capital seems like a high probability, given this company's history (they say mainly if an accretive opportunity arrives). Prospectus is now effective, but company has vowed to issue equity only on decent terms.
China Precision Steel (NASDAQ:CPSL)                          0.00            0.06 Nothing really exciting here. Expects volatility in demand. Capital raise is a high probabiilty. Sells below book for a reason. Cash flow is negative due to advance to suppliers. Effective internal controls.
China Health Industries (OTC BB:CHHE)                          0.06            0.04   Been stuck in an EPS range  of $0.04 to $0.06 for several quarters. However,based on guidance, the company could break out to $0.08 per quarter. cash needs seem adequate for next six months. Used to be a GeoSpecial (coded at $0.55) before China RTO turmoil hit the scene. Effective internal controls.
Befut Intl Co (OTC BB:BFTI)                          0.07           0.03 Has had six quarters of EPS growth in a row. EPS for last three qtrs. have been sequentially stagnant which could imply that the company may have to tap financial markets. However, company seems akin to will exploring options other than to equity.Effective internal controls.
Tianyin Pharmaceuticals Co (NYSE AMEX:TPI)     0.13        0.14           0.08  Company has two above average EPS growth comps left, as fiscal 201 EPS growth is expected to slow down to 14%. SAIC filings do not match (is an FIE). Have asked the company to comment on mis-match months ago. If they can offer a valid explanation, we believe the stock could experience an immediate expansion of its P/E multiple. Stock has retraced its price gains it made since earnings announcement.Effective internal controls.
Orient Paper (NYSE AMEX:ONP)     0.21           0.36          0.26 Analyst estimates show 2011 estimates at 1.00, well below company guidance. Applying company guidance will lilkely result in GPR of 4. The fact that ONP has issued EPS guidance implies that an equity offering is not in the card as do statements in its 2010 third quarter 10Q. Effective internal controls.
Hollysys Automation Tech (NASDAQ:HOLI)     0.19          0.27           0.11  Quarterly EPS growth is expected to be sporadic, HOLI crushed estimates, which will force us to monitor this company closely and analyst EPS estimate revisions. Guidance was raised, but not commensurate with this quarters strong beat. Effective internal controls.
China Nutrifruit Group (NYSE AMEX:CNGL)     0.15           0.15           0.11  Company has maintained guidance.EPS growth rate is not exciting and expansion uncertainty regarding the proposed dual listing of the stock in  Taiwan may be a short-term obstacle. Rodman note: "Visibility on FY2012 outlook is limited given that capacity expansion is predicated upon the size and pricing of the primary portion (5MM shares expected) of the TDR offering."  Minimal/inconsistent EPS growth will limit price appreciation past a repricing of risk of premium if quality is restored in the ChinaHybrid space. Quarterly EPS growth consistency has been a problem, which will limit P/E expansion. The company raised $13.3 million dollars in late 2009 and seems eager to raise money once again.  Effective internal controls.
Yucheng Technologies (NASDAQ:YTEC)     0.13           0.16          (0.33)  Company issued 2011 EPS guidance of $0.45 is higher than analyst estimates. It appears that company does not see equity markets as the primary source of capital. Maybe a reason why the stock is selling at a higher P/E than the average ChinaHybrid. Based on analyst estimates, consistent EPS growth on a quarterly basis my not be in the  cards for this company. Selling below book value per share of $4.62.  Effective internal controls.
China Medical Technologies (NASDAQ:CMED)                        0.43          0.26    EPS is expected to grow another 26.4% for fiscal 2012 ending December. Investors should be aware that a related party receivable of $18.0 million remains outstanding. However, the company has reduced the receivable amount from $30.0 million in the fiscal 2011 second quarter. It is possible that as the remaining balance is paid down, this IPO with a top auditor could experience P/E expansion. We may nibble at this stock and would be more aggressive if quarterly analyst EPS estimates were available (assuming they were favorable on a consistent basis). The availability of quarterly EPS estimates could also aid with multiple expansion. Regardless the stock is selling at a PEG ratio of only 0.36.  Stock has slowly recovered from a sharp sell off in late November instigated by a convertible notes offering. Effective internal controls.
Yingli Green Energy Holdings (NYSE:YGE)      0.44
        0.57                0.06   Two more quarters left of at least 70% EPS growth, after which analyst estimates have EPS growth anemic for four consecutive quarters.  Effective internal controls.
Elong Adr (NASDAQ:LONG)      0.05              0.04                0.01     Expensive based on 2011 EPS estimate. Effective internal controls.
Semiconductor Mfg Adr (NYSE:SMI)    (0.05)               0.15          (0.14) The company reeled in its first profitable year in 5 years and expected momentum to continue. "All of this shows we have made significant progress compared to 12 months ago. We have confidence that our momentum will continue through 2011 and onwards."  We will track this story closely, but based on company guidance it will lose money for the 2011 first quarter. Ineffective internal controls.
                                                                                         
                                                                                         
                                                                                         

    
    Disclosure: None

    You agree that you shall not republish or redistribute in any medium any information on the GeoInvesting website without our express written authorization. You acknowledge that GeoInvesting is not registered as an exchange, broker-dealer or investment advisor under any federal or state securities laws, and that GeoInvesting has not provided you with any individualized investment advice or information. Nothing in the website should be construed to be an offer or sale of any security. You should consult your financial advisor before making any investment decision or engaging in any securities transaction as investing in any securities mentioned in the website may or may not be suitable to you or for your particular circumstances.